|
|
Profile
|
Delegates :
|
|
Incorporated :
, |
Paid in Capital :
Million yen |
Employees :
人 |
Address :
Marunouchi 1-6-2 Shinmarunouchi center building 16F, Chiyhoda-ku TOKYO
〒100-0005
|
TEL/FAX :
/ |
URL：
https://www.evaluate.com/ |
Attachment :
|
Mission/Background :
Evaluate Japan operates under the Citeline and Evaluate brands in Japan, supporting the pharmaceutical journey from development to commercialization. As a leading provider of industry-best data and consulting services, we empower strategic decision-making across the entire product lifecycle.
In addition to serving pharmaceutical and biotech companies, we work extensively with financial institutions, trading firms, and other related industries. To further enhance the value of our digital solutions and consulting services, we leverage NorstellaLinQ—one of the most comprehensive and integrated datasets in the industry, built from over 74 billion data points and powered by tokenization. Combined with deep expertise from our team of industry consultants, we deliver trusted, data-driven solutions that address critical business challenges.
|
|
Technology & Business
|
Evaluate Japan operates under two brands—Citeline and Evaluate—offering specialized solutions across the clinical and commercial spectrum.
Citeline provides support for clinical trial design, patient recruitment and retention, and regulatory/compliance guidance.
Evaluate delivers a wide range of commercial solutions, including market forecasting, portfolio strategy, M&A and licensing deal analysis, and competitive intelligence.
Together, these offerings help accelerate strategic planning and business execution.
|
|
Products & Service
|
Products & Service Name
|
Stage
|
Outline
|
Milestone
|
Citeline Smartsolutions
|
Launched
|
AI-powered solutions to optimize and accelerate clinical trial planning and site selection.
|
Significantly reduce the time required for clinical trial design at pharmaceutical and biotech companies.
|
Patient Match
|
Launched
|
A platform that leverages real-world data to identify patients most likely to qualify for clinical trials.
|
Significantly reduces patient recruitment timelines for pharmaceutical and biotech companies.
|
Evaluate Pharma
|
Launched
|
An industry-standard database offering pharmaceutical market forecasts and analytics.
|
Accelerate customer acquisition and growth.
|
J+D Forecasting
|
Launched
|
Quickly build and manage pharmaceutical forecasting models with our Excel add-in.
|
Enables transparent revenue forecasting workflows for pharma and biotech companies.
|
Custom Analytics & Consulting
|
Discovery
|
Industry experts provide strategic analysis and decision support tailored to your business challenges.
|
Accelerate customer acquisition and growth.
|
|
Highlights
|
Evaluate Japan was selected for Fast Company’s World’s Most Innovative Companies 2025 list. In October last year, we launched NorstellaLinQ, the most comprehensive and integrated dataset in the pharmaceutical industry, built from over 74 billion tokenized and connected data points to help solve critical business challenges.
In Japan, we also provide pharmaceutical market data to leading media outlets such as Nikkei, Toyo Keizai, and Iyaku Keizai.
|
|
|